AdaptHealth (AHCO) to Release Earnings on Tuesday

AdaptHealth (NASDAQ:AHCO - Get Free Report) is expected to release its Q1 2025 earnings data before the market opens on Tuesday, May 6th. Analysts expect AdaptHealth to post earnings of $0.01 per share and revenue of $764.77 million for the quarter.

AdaptHealth Price Performance

Shares of AHCO traded up $0.28 during midday trading on Friday, hitting $8.78. 1,737,580 shares of the company traded hands, compared to its average volume of 1,261,673. AdaptHealth has a 52 week low of $7.11 and a 52 week high of $11.90. The company has a debt-to-equity ratio of 1.34, a quick ratio of 1.00 and a current ratio of 1.24. The firm has a 50 day moving average of $9.53 and a 200-day moving average of $9.81. The stock has a market cap of $1.18 billion, a price-to-earnings ratio of -5.32, a PEG ratio of 1.08 and a beta of 1.64.

Wall Street Analyst Weigh In

AHCO has been the subject of several research analyst reports. Royal Bank of Canada raised their price target on AdaptHealth from $11.00 to $14.00 and gave the company an "outperform" rating in a report on Wednesday, February 26th. UBS Group reduced their price target on shares of AdaptHealth from $12.00 to $11.00 and set a "buy" rating on the stock in a research report on Thursday, February 13th. Truist Financial increased their price objective on shares of AdaptHealth from $12.00 to $14.00 and gave the company a "buy" rating in a research report on Wednesday, February 26th. Canaccord Genuity Group boosted their target price on shares of AdaptHealth from $13.00 to $14.00 and gave the stock a "buy" rating in a report on Wednesday, February 26th. Finally, Robert W. Baird upped their target price on shares of AdaptHealth from $14.00 to $16.00 and gave the company an "outperform" rating in a research report on Thursday, February 27th. Five investment analysts have rated the stock with a buy rating, According to MarketBeat, the company has an average rating of "Buy" and a consensus target price of $13.80.

AdaptHealth Company Profile

AdaptHealth Corp., together with its subsidiaries, sells home medical equipment (HME), medical supplies, and home and related services in the United States. The company provides sleep therapy equipment, supplies, and related services, such as CPAP and bi-PAP services to individuals suffering from obstructive sleep apnea; medical devices and supplies, including continuous glucose monitors and insulin pumps for the treatment of diabetes; HME to patients discharged from acute care and other facilities; oxygen and related chronic therapy services in the home; and other HME devices and supplies on behalf of chronically ill patients with wound care, urological, incontinence, ostomy, and nutritional supply needs.